(Q44276671)
Statements
Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer (English)
Charles Levenback
David M Gershenson
Judith K Wolf
Jacalyn Gano
J Taylor Wharton
John J Kavanagh